Nanuet, NY, United States of America

Mohammed Taleb

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Mohammed Taleb: Pioneering Cannabinoid Releases

Introduction: Mohammed Taleb is a notable inventor based in Nanuet, NY, known for his significant contributions to the field of cannabinoid formulation. With a total of three patents to his name, Taleb is at the forefront of innovations that enhance the delivery and effectiveness of cannabinoids through advanced formulations.

Latest Patents: Among Mohammed Taleb's latest patents are his groundbreaking works on immediate release formulations of cannabinoids. These compositions feature a population of particles, each potentially containing one or more cannabinoids alongside various intra-granule excipients. In another variation, the particles may also include a porous bead core. The preparation methods for these compositions are varied, including techniques such as fluid bed granulation, shear-induced wet granulation, or spray granulation. These innovations aim to ensure efficient and effective cannabinoid release, showcasing Taleb's commitment to enhancing therapeutic applications.

Career Highlights: Currently, Mohammed Taleb is associated with Glatt GmbH, where he applies his expertise to develop cutting-edge cannabinoid formulations. His work represents a fusion of scientific knowledge and practical application, making him a valuable asset in the field of pharmaceutical innovation.

Collaborations: Throughout his career, Taleb has collaborated with talented individuals such as Reinhard Nowak and Zafar Iqbal. These partnerships have fostered an environment of creativity and innovation, propelling advancements in cannabinoid research.

Conclusion: Mohammed Taleb's contributions to cannabinoid formulations position him as a leading inventor in the industry. His innovative approaches and collaborative spirit continue to drive the development of effective cannabinoid therapies, making a lasting impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…